In Israel, the research & development by business enterprise, pharmaceutical industry in constant ppp $ stands at 232.36 million, reflecting an increase of 34.71 million (17.6%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Israel
No matching regions
More indicators for Israel
Higher-education-finacing R&D financed by general university in local currency
45,344.58M
+245.57M
(2021)
R&D financed by rest of the world in local currency
423,296.97M
+13,026.75M
(2021)
Government R&D financed by rest of the world in local currency
29.43M
+1.94M
(2021)
Business R&D financed by rest of the world in local currency
412,451.33M
+13,420.49M
(2021)
Non-profit R&D growth rate
7.53%
+6.36%
(2022)
Israel Business R&D pharmaceutical in constant PPP $ between 2010 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 232.36M | +34.71M |
| 2020 | 197.65M | +8.35M |
| 2019 | 189.31M | +3.26M |
| 2018 | 186.05M | -65.52M |
| 2017 | 251.57M | -77.89M |
| 2016 | 329.46M | -20.68M |
| 2015 | 350.14M | +63.04M |
| 2014 | 287.11M | -99.86M |
| 2013 | 386.97M | +84.69M |
| 2012 | 302.28M | -5.93M |
| 2011 | 308.21M | -40.88M |
| 2010 | 349.09M |